| Clinical quantitative susceptibility mapping (QSM): biometal imaging and its emerging roles in patient care Y Wang, P Spincemaille, Z Liu, A Dimov, K Deh, J Li, Y Zhang, Y Yao, ... Journal of magnetic resonance imaging 46 (4), 951-971, 2017 | 357 | 2017 |
| Quantitative susceptibility mapping (QSM) of white matter multiple sclerosis lesions: interpreting positive susceptibility and the presence of iron C Wisnieff, S Ramanan, J Olesik, S Gauthier, Y Wang, D Pitt Magnetic resonance in medicine 74 (2), 564-570, 2015 | 316 | 2015 |
| Quantitative susceptibility mapping of multiple sclerosis lesions at various ages W Chen, SA Gauthier, A Gupta, J Comunale, T Liu, S Wang, M Pei, D Pitt, ... Radiology 271 (1), 183-192, 2014 | 293 | 2014 |
| Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis BI Glanz, CM Holland, SA Gauthier, EL Amunwa, Z Liptak, MK Houtchens, ... Multiple sclerosis journal 13 (8), 1004-1010, 2007 | 269 | 2007 |
| Quantitative susceptibility mapping identifies inflammation in a subset of chronic multiple sclerosis lesions UW Kaunzner, Y Kang, S Zhang, E Morris, Y Yao, S Pandya, ... Brain 142 (1), 133-145, 2019 | 236 | 2019 |
| MRI in the assessment and monitoring of multiple sclerosis: an update on best practice UW Kaunzner, SA Gauthier Therapeutic advances in neurological disorders 10 (6), 247-261, 2017 | 191 | 2017 |
| A model for the comprehensive investigation of a chronic autoimmune disease: the multiple sclerosis CLIMB study SA Gauthier, BI Glanz, M Mandel, HL Weiner Autoimmunity reviews 5 (8), 532-536, 2006 | 164 | 2006 |
| Imaging chronic active lesions in multiple sclerosis: a consensus statement F Bagnato, P Sati, CC Hemond, C Elliott, SA Gauthier, DM Harrison, ... Brain 147 (9), 2913-2933, 2024 | 157 | 2024 |
| Global estimates of informal care A Wimo, S Gauthier, M Prince London: Alzheimer’s Disease International (ADI), 2018 | 143 | 2018 |
| Reproducibility of quantitative susceptibility mapping in the brain at two field strengths from two vendors K Deh, TD Nguyen, S Eskreis‐Winkler, MR Prince, P Spincemaille, ... Journal of magnetic resonance imaging 42 (6), 1592-1600, 2015 | 141 | 2015 |
| Longitudinal change in magnetic susceptibility of new enhanced multiple sclerosis (MS) lesions measured on serial quantitative susceptibility mapping (QSM) Y Zhang, SA Gauthier, A Gupta, J Comunale, G Chia‐Yi Chiang, D Zhou, ... Journal of magnetic resonance imaging 44 (2), 426-432, 2016 | 121 | 2016 |
| Feasibility and reproducibility of whole brain myelin water mapping in 4 minutes using fast acquisition with spiral trajectory and adiabatic T2prep (FAST‐T2) at 3T TD Nguyen, K Deh, E Monohan, S Pandya, P Spincemaille, A Raj, ... Magnetic resonance in medicine 76 (2), 456-465, 2016 | 112 | 2016 |
| Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography AA Khanifar, GJ Parlitsis, JR Ehrlich, GD Aaker, DJ D’Amico, SA Gauthier, ... Clinical ophthalmology, 1007-1013, 2010 | 109 | 2010 |
| HLA B* 44: protective effects in MS susceptibility and MRI outcome measures BC Healy, M Liguori, D Tran, T Chitnis, B Glanz, C Wolfish, S Gauthier, ... Neurology 75 (7), 634-640, 2010 | 107 | 2010 |
| T2prep three‐dimensional spiral imaging with efficient whole brain coverage for myelin water quantification at 1.5 tesla TD Nguyen, C Wisnieff, MA Cooper, D Kumar, A Raj, P Spincemaille, ... Magnetic resonance in medicine 67 (3), 614-621, 2012 | 95 | 2012 |
| Quantitative susceptibility mapping and R2* measured changes during white matter lesion development in multiple sclerosis: myelin breakdown, myelin debris degradation and … Y Zhang, SA Gauthier, A Gupta, W Chen, J Comunale, GCY Chiang, ... American Journal of Neuroradiology 37 (9), 1629-1635, 2016 | 94 | 2016 |
| QSM is an imaging biomarker for chronic glial activation in multiple sclerosis lesions KM Gillen, M Mubarak, C Park, G Ponath, S Zhang, A Dimov, ... annals of Clinical and Translational Neurology 8 (4), 877-886, 2021 | 91 | 2021 |
| Deep grey matter injury in multiple sclerosis: a NAIMS consensus statement D Ontaneda, PC Raza, KR Mahajan, DL Arnold, MG Dwyer, SA Gauthier, ... Brain 144 (7), 1974-1984, 2021 | 89 | 2021 |
| Toward precision phenotyping of multiple sclerosis D Pitt, CH Lo, SA Gauthier, RA Hickman, E Longbrake, LM Airas, ... Neurology: Neuroimmunology & Neuroinflammation 9 (6), e200025, 2022 | 85 | 2022 |
| Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis EW Radue, WH Stuart, PA Calabresi, C Confavreux, SL Galetta, ... Journal of the neurological sciences 292 (1-2), 28-35, 2010 | 85 | 2010 |
